Skip to results
1-20 of 58
Authors: Laure Gossec
Sort by
Journal Article
P174 Bimekizumab-treated patients with active psoriatic arthritis showed sustained improvements in pain and fatigue: up to 2-year results from two Phase 3 studies Free
Philip J Mease and others
in
Rheumatology
Rheumatology, Volume 64, Issue Supplement_3, April 2025, keaf142.211, https://doi.org/10.1093/rheumatology/keaf142.211
Published: 28 April 2025
Journal Article
E090 Guselkumab and IL-17 inhibitors improve patient-perceived impact of psoriatic arthritis similarly: 6-month interim results of the PsABIOnd observational cohort study Free
Stefan Siebert and others
in
Rheumatology
Rheumatology, Volume 64, Issue Supplement_3, April 2025, keaf142.325, https://doi.org/10.1093/rheumatology/keaf142.325
Published: 28 April 2025
Journal Article
Variability of Psoriatic Arthritis Impact of Disease questionnaire (PsAID12) thresholds in psoriatic arthritis: data from the ReFlaP study Open Access
Clementina López-Medina and others
in
Rheumatology
Rheumatology, Volume 64, Issue 5, May 2025, Pages 3090–3094, https://doi.org/10.1093/rheumatology/keaf002
Published: 03 January 2025
Journal Article
Ultrasonography for the assessment of enthesitis in psoriatic arthritis: systematic review with meta-analysis
Get access
Noémie Bibas and others
in
Rheumatology
Rheumatology, Volume 64, Issue 5, May 2025, Pages 2377–2384, https://doi.org/10.1093/rheumatology/keae705
Published: 20 December 2024
Journal Article
Multi-domain effectiveness of guselkumab evaluated via composite indices through 1 year in patients with PsA and inadequate response to TNFi: post hoc analysis of COSMOS Open Access
Laure Gossec and others
in
Rheumatology
Rheumatology, Volume 64, Issue 5, May 2025, Pages 2565–2574, https://doi.org/10.1093/rheumatology/keae586
Published: 22 October 2024
Journal Article
Subclinical psoriatic arthritis and disease interception—where are we in 2024? Open Access
Clementina López-Medina and others
in
Rheumatology
Rheumatology, Volume 64, Issue 1, January 2025, Pages 56–64, https://doi.org/10.1093/rheumatology/keae399
Published: 16 August 2024
Journal Article
Effect of bimekizumab on patient-reported disease impact in patients with psoriatic arthritis: 1-year results from two phase 3 studies Open Access
Laure Gossec and others
in
Rheumatology
Rheumatology, Volume 63, Issue 9, September 2024, Pages 2399–2410, https://doi.org/10.1093/rheumatology/keae277
Published: 16 May 2024
Journal Article
OA23 Time to address the challenge of difficult-to-treat psoriatic arthritis: results from an international survey Free
Helena Marzo-Ortega and others
in
Rheumatology
Rheumatology, Volume 63, Issue Supplement_1, April 2024, keae163.023, https://doi.org/10.1093/rheumatology/keae163.023
Published: 24 April 2024
Journal Article
Coalition for Health and Gender Equity (CHANGE)—a protocol for a global cross-sectional survey of health and gender equity in rheumatology Open Access
Tayyeba Khursheed and others
Rheumatology Advances in Practice, Volume 8, Issue 2, 2024, rkae021, https://doi.org/10.1093/rap/rkae021
Published: 10 February 2024
Journal Article
How do patient-reported outcome measures affect treatment intensification and patient satisfaction in the management of psoriatic arthritis? A cross sectional study of 503 patients Open Access
Conor Coyle and others
in
Rheumatology
Rheumatology, Volume 64, Issue 1, January 2025, Pages 242–251, https://doi.org/10.1093/rheumatology/kead679
Published: 08 January 2024
Journal Article
An international multicentre analysis of current prescribing practices and shared decision-making in psoriatic arthritis Open Access
Lily Watson and others
in
Rheumatology
Rheumatology, Volume 63, Issue 12, December 2024, Pages 3449–3456, https://doi.org/10.1093/rheumatology/kead621
Published: 27 November 2023
Journal Article
P174 Psoriatic arthritis patients in the UK have a lower quality of life than patients in mainland Europe - an analysis from the ASSIST study Free
Conor Coyle and others
in
Rheumatology
Rheumatology, Volume 62, Issue Supplement_2, April 2023, kead104.215, https://doi.org/10.1093/rheumatology/kead104.215
Published: 24 April 2023
Journal Article
P178 Current prescribing practices in psoriatic arthritis - comparison between the UK and Europe Free
Lily Watson and others
in
Rheumatology
Rheumatology, Volume 62, Issue Supplement_2, April 2023, kead104.219, https://doi.org/10.1093/rheumatology/kead104.219
Published: 24 April 2023
Journal Article
P179 Shared decision-making in psoriatic arthritis consultations Free
Lily L Watson and others
in
Rheumatology
Rheumatology, Volume 62, Issue Supplement_2, April 2023, kead104.220, https://doi.org/10.1093/rheumatology/kead104.220
Published: 24 April 2023
Journal Article
Gender-specific differences in patients with psoriatic arthritis receiving ustekinumab or tumour necrosis factor inhibitor: real-world data Open Access
Arno W R Van Kuijk and others
in
Rheumatology
Rheumatology, Volume 62, Issue 10, October 2023, Pages 3382–3390, https://doi.org/10.1093/rheumatology/kead089
Published: 22 February 2023
Journal Article
Evaluation of the agreement between the ACR 1990 fibromyalgia tender points and an enthesitis score in patients with axial spondyloarthritis Free
Faten Hamitouche and others
in
Rheumatology
Rheumatology, Volume 62, Issue 8, August 2023, Pages 2757–2764, https://doi.org/10.1093/rheumatology/keac683
Published: 27 December 2022
Journal Article
P61 SARS-CoV-2 vaccine safety in adolescents with inflammatory rheumatic and musculoskeletal diseases and adults with juvenile idiopathic arthritis: data from the EULAR COVAX physician-reported registry Open Access
Saskia Lawson-Tovey and others
Rheumatology Advances in Practice, Volume 6, Issue Supplement_1, October 2022, rkac067.061, https://doi.org/10.1093/rap/rkac067.061
Published: 28 September 2022
Journal Article
Obstetric outcomes in women with rheumatic disease and COVID-19 in the context of vaccination status Open Access
Sinead Maguire and others
in
Rheumatology
Rheumatology, Volume 62, Issue 4, April 2023, Pages 1621–1626, https://doi.org/10.1093/rheumatology/keac534
Published: 19 September 2022
Journal Article
Effect of bimekizumab on symptoms and impact of disease in patients with psoriatic arthritis over 3 years: results from BE ACTIVE Open Access
Philip J Mease and others
in
Rheumatology
Rheumatology, Volume 62, Issue 2, February 2023, Pages 617–628, https://doi.org/10.1093/rheumatology/keac353
Published: 05 July 2022
Journal Article
Guselkumab provides sustained domain-specific and comprehensive efficacy using composite indices in patients with active psoriatic arthritis Open Access
Laura C Coates and others
in
Rheumatology
Rheumatology, Volume 62, Issue 2, February 2023, Pages 606–616, https://doi.org/10.1093/rheumatology/keac375
Published: 29 June 2022